Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malou Philips

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Applied Laboratory Medicine|January 3, 2022
Diagnosis of Thrombotic Thrombocytopenic Purpura by ADAMTS13 Activity QuantificationKonstantinos Dimopoulos, Malou Philips, Jens P Goetze
Thrombosis Research|February 10, 2015
Comparison of automated von Willebrand factor activity assaysAnnette Timm, Andreas Hillarp, Malou Philips, et al.
European Journal of Haematology|February 13, 2020
Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-reviewKatrine Laura Rasmussen, Malou Philips, Armando Tripodi, et al.
Ugeskrift for Laeger|May 1, 2019
[Diagnosing von Willebrand disease]Fie Juhl Vojdeman, Malou Philips, Eva Funding, et al.
Thrombosis and Haemostasis|August 12, 2008
Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand diseaseElsa Lanke, Ann-Charlotte Kristoffersson, Malou Philips, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 17, 2009
Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperatureSixtus Thorsen, Ane Teisner, Søren Astrup Jensen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Applied Laboratory Medicine|January 3, 2022
Diagnosis of Thrombotic Thrombocytopenic Purpura by ADAMTS13 Activity QuantificationKonstantinos Dimopoulos, Malou Philips, Jens P Goetze
Thrombosis Research|February 10, 2015
Comparison of automated von Willebrand factor activity assaysAnnette Timm, Andreas Hillarp, Malou Philips, et al.
European Journal of Haematology|February 13, 2020
Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-reviewKatrine Laura Rasmussen, Malou Philips, Armando Tripodi, et al.
Ugeskrift for Laeger|May 1, 2019
[Diagnosing von Willebrand disease]Fie Juhl Vojdeman, Malou Philips, Eva Funding, et al.
Thrombosis and Haemostasis|August 12, 2008
Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand diseaseElsa Lanke, Ann-Charlotte Kristoffersson, Malou Philips, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 17, 2009
Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperatureSixtus Thorsen, Ane Teisner, Søren Astrup Jensen, et al.
Pageof 1